On the public citation graph

Nanoparticle formulations in pulmonary drug delivery

0 signed · 370 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/14651858.cd003063.pub3openalex-snapshot
Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome
inferredcites →https://doi.org/10.1002/cbic.200400174openalex-snapshot
Transport Of Surface‐Modified Nanoparticles Through Cell Monolayers
inferredcites →https://doi.org/10.1002/jps.10152openalex-snapshot
Factors Affecting the Deposition of Inhaled Porous Drug Particles
inferredcites →https://doi.org/10.1002/jps.10193openalex-snapshot
Micronization of insulin from halogenated alcohol solution using supercritical carbon dioxide as an antisolvent
inferredcites →https://doi.org/10.1002/jps.20607openalex-snapshot
Pharmacokinetics of 5-fluorouracil in the hamster following inhalation delivery of lipid-coated nanoparticles
inferredcites →https://doi.org/10.1016/j.addr.2004.07.003openalex-snapshot
Nanotechnology: challenging the limit of creativity in targeted drug delivery
inferredcites →https://doi.org/10.1016/j.addr.2007.04.010openalex-snapshot
Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system☆
inferredcites →https://doi.org/10.1016/j.addr.2007.05.013openalex-snapshot
Prodrug strategies to overcome poor water solubility
inferredcites →https://doi.org/10.1016/j.bbrc.2004.04.067openalex-snapshot
Incorporation of biodegradable nanoparticles into human airway epithelium cells—in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases
inferredcites →https://doi.org/10.1016/j.biomaterials.2005.03.033openalex-snapshot
AC electrospray biomaterials synthesis
inferredcites →https://doi.org/10.1016/j.ejpb.2004.03.008openalex-snapshot
PLGA–PEI nanoparticles for gene delivery to pulmonary epithelium
inferredcites →https://doi.org/10.1016/j.ejpb.2006.05.012openalex-snapshot
Comparison of permeation enhancing strategies for an oral factor Xa inhibitor using the Caco-2 cell monolayer model
inferredcites →https://doi.org/10.1016/j.ejpb.2006.10.021openalex-snapshot
Effervescent dry powder for respiratory drug delivery
inferredcites →https://doi.org/10.1016/j.ejpb.2007.10.017openalex-snapshot
Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins
inferredcites →https://doi.org/10.1016/j.ejphar.2005.12.068openalex-snapshot
Nanomedicine for respiratory diseases
inferredcites →https://doi.org/10.1016/j.ejps.2005.04.009openalex-snapshot
Microencapsulated chitosan nanoparticles for lung protein delivery
inferredcites →https://doi.org/10.1016/j.ijpharm.2003.09.041openalex-snapshot
Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung
inferredcites →https://doi.org/10.1016/j.ijpharm.2003.11.003openalex-snapshot
Rapid dissolving high potency danazol powders produced by spray freezing into liquid process
inferredcites →https://doi.org/10.1016/j.ijpharm.2006.02.014openalex-snapshot
Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery
inferredcites →https://doi.org/10.1016/j.ijpharm.2006.04.012openalex-snapshot
Cryogenic liquids, nanoparticles, and microencapsulation
inferredcites →https://doi.org/10.1016/j.ijpharm.2006.05.048openalex-snapshot
Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants
inferredcites →https://doi.org/10.1016/j.ijpharm.2007.11.011openalex-snapshot
Synthesis, physicochemical properties and in vitro cytotoxicity of nicotinic acid ester prodrugs intended for pulmonary delivery using perfluorooctyl bromide as vehicle
inferredcites →https://doi.org/10.1016/j.ijpharm.2008.02.011openalex-snapshot
Inhaled nanoparticles—A current review
inferredcites →https://doi.org/10.1016/j.jconrel.2004.08.005openalex-snapshot
Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes
inferredcites →https://doi.org/10.1016/j.jconrel.2005.09.036openalex-snapshot
Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG–PEI
inferredcites →https://doi.org/10.1016/j.jconrel.2007.06.001openalex-snapshot
Preparation of drug nanoparticle-containing microparticles using a 4-fluid nozzle spray drier for oral, pulmonary, and injection dosage forms
inferredcites →https://doi.org/10.1016/j.jconrel.2007.10.011openalex-snapshot
Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats
inferredcites →https://doi.org/10.1016/j.nano.2004.11.003openalex-snapshot
What is nanomedicine?
inferredcites →https://doi.org/10.1016/j.taap.2006.01.016openalex-snapshot
Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung
inferredcites →https://doi.org/10.1016/j.tibtech.2007.09.005openalex-snapshot
Nanoparticles for drug delivery to the lungs
inferredcites →https://doi.org/10.1016/s0168-3659(01)00552-1openalex-snapshot
Sustained-delivery of an apolipoproteinE–peptidomimetic using multivesicular liposomes lowers serum cholesterol levels
inferredcites →https://doi.org/10.1016/s0168-3659(03)00359-6openalex-snapshot
Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery
inferredcites →https://doi.org/10.1016/s0169-409x(00)00118-6openalex-snapshot
Nanosuspensions as particulate drug formulations in therapy
inferredcites →https://doi.org/10.1016/s0378-5173(01)00614-7openalex-snapshot
Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats
inferredcites →https://doi.org/10.1016/s0378-5173(01)00923-1openalex-snapshot
Characterization of nanoparticle uptake by endothelial cells
inferredcites →https://doi.org/10.1021/jm070836dopenalex-snapshot
Effect of Structural and Conformation Modifications, Including Backbone Cyclization, of Hydrophilic Hexapeptides on Their Intestinal Permeability and Enzymatic Stability
inferredcites →https://doi.org/10.1021/la0523661openalex-snapshot
Amorphous Drug Nanosuspensions. 1. Inhibition of Ostwald Ripening
inferredcites →https://doi.org/10.1021/la7020098openalex-snapshot
Biodegradable Nanoparticle Flocculates for Dry Powder Aerosol Formulation
inferredcites →https://doi.org/10.1023/a:1014276917363openalex-snapshot
Production and Characterization of a Budesonide Nanosuspension for Pulmonary Administration
inferredcites →https://doi.org/10.1023/a:1020178304031openalex-snapshot
Biophysical Aspects of Using Liposomes as Delivery Vehicles
inferredcites →https://doi.org/10.1023/a:1023899505837openalex-snapshot
Chemical Stability of Esters of Nicotinic Acid Intended for Pulmonary Administration by Liquid Ventilation
inferredcites →https://doi.org/10.1023/b:pham.0000008051.94834.10openalex-snapshot
Surfactant-Free, Biodegradable Nanoparticles for Aerosol Therapy Based on the Branched Polyesters, DEAPA-PVAL-g-PLGA
inferredcites →https://doi.org/10.1023/b:pham.0000041446.14569.e2openalex-snapshot
Insulin Nanoparticles: A Novel Formulation Approach for Poorly Water Soluble Zn-Insulin
inferredcites →https://doi.org/10.1038/nbt0104-19openalex-snapshot
Health impact of nanomaterials?
inferredcites →https://doi.org/10.1038/nm0903-1100openalex-snapshot
News Feature: Technologies that deliver
inferredcites →https://doi.org/10.1038/nrd1494openalex-snapshot
Nanosuspensions in drug delivery
inferredcites →https://doi.org/10.1038/nrd2153openalex-snapshot
Inhaling medicines: delivering drugs to the body through the lungs
inferredcites →https://doi.org/10.1042/bst0350527openalex-snapshot
Health effects of nanomaterials
inferredcites →https://doi.org/10.1056/nejmct063533openalex-snapshot
Inhaled Insulin for Diabetes Mellitus
inferredcites →https://doi.org/10.1073/pnas.0636277100openalex-snapshot
Efficient active transport of gene nanocarriers to the cell nucleus
inferredcites →https://doi.org/10.1080/08958370490439597openalex-snapshot
Translocation of Inhaled Ultrafine Particles to the Brain
inferredcites →https://doi.org/10.1080/08958370490439650openalex-snapshot
Long-Term Clearance Kinetics of Inhaled Ultrafine Insoluble Iridium Particles from the Rat Lung, Including Transient Translocation into Secondary Organs
inferredcites →https://doi.org/10.1089/dia.2007.0228openalex-snapshot
Inhalation, Deposition, and Fate of Insulin and Other Therapeutic Proteins
inferredcites →https://doi.org/10.1089/jamp.2007.0656openalex-snapshot
Aerosolized Chemotherapy
inferredcites →https://doi.org/10.1093/jac/dkg477openalex-snapshot
Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis
inferredcites →https://doi.org/10.1097/00063198-200304001-00004openalex-snapshot
Novolizer®
inferredcites →https://doi.org/10.1097/01.pcc.0000282158.09783.7copenalex-snapshot
Selective medicated (normal saline and exogenous surfactant) bronchoalveolar lavage in severe aspiration syndrome in children*
inferredcites →https://doi.org/10.1111/j.1742-1241.2007.01382.xopenalex-snapshot
The DiskusTM: a review of its position among dry powder inhaler devices
inferredcites →https://doi.org/10.1146/annurev.bioeng.4.100101.132311openalex-snapshot
Bioengineering of Therapeutic Aerosols
inferredcites →https://doi.org/10.1152/jappl.2001.91.6.2735openalex-snapshot
Electro-hydrodynamic atomization of drug solutions for inhalation purposes
inferredcites →https://doi.org/10.1159/000111774openalex-snapshot
Dry Powder Inhalers and the Risk of Error
inferredcites →https://doi.org/10.1163/156855207780208592openalex-snapshot
Engineering of poly(DL-lactic-co-glycolic acid) nanocomposite particles for dry powder inhalation dosage forms of insulin with the spray-fluidized bed granulating system
inferredcites →https://doi.org/10.1177/002013240204701204openalex-snapshot
The Electrospray and Its Application to Targeted Drug Inhalation
inferredcites →https://doi.org/10.1211/0022357011775190openalex-snapshot
Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium
inferredcites →https://doi.org/10.1211/jpp.58.10.0005openalex-snapshot
Histological evaluation of buccal penetration enhancement properties of chitosan and trimethyl chitosan
inferredcites →https://doi.org/10.1211/jpp.59.1.0010openalex-snapshot
Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification
inferredcites →https://doi.org/10.1513/pats.200403-025msopenalex-snapshot
How the Lung Handles Drugs: Pharmacokinetics and Pharmacodynamics of Inhaled Corticosteroids
inferredcites →https://doi.org/10.1517/13543776.15.3.249openalex-snapshot
Nanotechnology in the pharmaceutical industry
inferredcites →https://doi.org/10.1517/17425247.4.6.595openalex-snapshot
The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects
inferredcites →https://doi.org/10.1517/17425247.4.6.607openalex-snapshot
The nanoscale in pulmonary delivery. Part 2: formulation platforms
inferredcites →https://doi.org/10.2165/00003088-200443120-00002openalex-snapshot
Clinical Pharmacokinetics and Pharmacodynamics of Inhaled Insulin
inferredcites →https://doi.org/10.2165/00151829-200504010-00007openalex-snapshot
The Novolizer??
inferredcites →https://doi.org/10.2174/156720107780362339openalex-snapshot
Recent Advances in Protein and Peptide Drug Delivery Systems
inferredcites →https://doi.org/10.2337/diacare.26.3.764openalex-snapshot
Inhaled Insulin Using the AERx Insulin Diabetes Management System in Healthy and Asthmatic Subjects
inferredcites →https://doi.org/10.3109/10837459609022594openalex-snapshot
Comparison of a Respiratory Suspension Aerosolized by an Air-Jet and an Ultrasonic Nebulizer
inferredcites →https://doi.org/10.3310/hta5260openalex-snapshot
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.5003878openalex-extracted
Optimization of Curcumin-Loaded Spray-Dried Aerosol Dry Powder Nanocomposite Microparticle Properties Via Design of Experiment
inferred← citeshttps://doi.org/10.1002/9780470747803.ch3openalex-snapshot
Considerations for the Design of Toxicity Studies of Inhaled Nanomedicines
inferred← citeshttps://doi.org/10.1002/9781118794203.ch13openalex-snapshot
Liposome‐Based Mucoadhesive Formulations
inferred← citeshttps://doi.org/10.1002/9781118799536.ch3openalex-snapshot
Dry Powder Inhalation for Pulmonary Delivery: Recent Advances and Continuing Challenges
inferred← citeshttps://doi.org/10.1002/9781118856017.ch12openalex-snapshot
Inhalation Pathway as a Promising Portal of Entry: What Has to Be Considered in Designing New Nanomaterials for Biomedical Application?
inferred← citeshttps://doi.org/10.1002/9781119962977.ch11openalex-snapshot
Chitosan‐Based Systems for Mucosal Delivery of Biopharmaceuticals
inferred← citeshttps://doi.org/10.1002/9783527800681.ch15openalex-snapshot
Computational Predictive Models for Nanomedicine
inferred← citeshttps://doi.org/10.1002/adfm.201804229openalex-snapshot
Structure‐Guided Engineering of Cytotoxic Cabazitaxel for an Adaptive Nanoparticle Formulation: Enhancing the Drug Safety and Therapeutic Efficacy
inferred← citeshttps://doi.org/10.1002/adhm.202301577openalex-snapshot
Targeted Delivery of the Pan‐Inflammasome Inhibitor MM01 as an Alternative Approach to Acute Lung Injury Therapy
inferred← citeshttps://doi.org/10.1002/adhm.202502254openalex-snapshot
Organ‐Targeted and Organelle‐Targeted Liposome Gene Vector Construction
inferred← citeshttps://doi.org/10.1002/adma.202414336openalex-snapshot
Development of an Inhalable DNA Tetrahedron MicroRNA Sponge
inferred← citeshttps://doi.org/10.1002/chin.200917255openalex-snapshot
ChemInform Abstract: Nanoparticle Formulations in Pulmonary Drug Delivery
inferred← citeshttps://doi.org/10.1002/iub.481openalex-snapshot
Lung vascular targeting through inhalation delivery: Insight from filamentous viruses and other shapes
inferred← citeshttps://doi.org/10.1002/jps.23980openalex-snapshot
NanoClusters Surface Area Allows Nanoparticle Dissolution with Microparticle Properties
inferred← citeshttps://doi.org/10.1002/jps.23996openalex-snapshot
The Role of Payload Hydrophobicity in Nanotherapeutic Pharmacokinetics
inferred← citeshttps://doi.org/10.1002/jps.24098openalex-snapshot
A Brief Literature and Patent Review of Nanosuspensions to a Final Drug Product
inferred← citeshttps://doi.org/10.1002/slct.202301113openalex-snapshot
Bio‐fabrication of Silver Nanoparticles Using Alysicarpus vaginalis Extract: Preparation, Characterization and Comparative in vitro Antibacterial Evaluations
inferred← citeshttps://doi.org/10.1002/wnan.1401openalex-snapshot
Polymeric nanoparticles in development for treatment of pulmonary infectious diseases
inferred← citeshttps://doi.org/10.1002/wnan.1933openalex-snapshot
Pulmonary delivery of nano‐particles for lung cancer diagnosis and therapy: Recent advances and future prospects
inferred← citeshttps://doi.org/10.1007/978-1-4419-9745-6_12openalex-snapshot
Polymers for Pulmonary Drug Delivery
inferred← citeshttps://doi.org/10.1007/978-1-4419-9745-6_13openalex-snapshot
Particle Engineering Technologies for Pulmonary Drug Delivery
inferred← citeshttps://doi.org/10.1007/978-1-4419-9745-6_21openalex-snapshot
Development and Approval of Inhaled Respiratory Drugs: A US Regulatory Science Perspective
inferred← citeshttps://doi.org/10.1007/978-1-4419-9745-6_8openalex-snapshot
Science and Technology of Pressurized Metered-Dose Inhalers
inferred← citeshttps://doi.org/10.1007/978-1-4614-9164-4_19openalex-snapshot
Peptides, Proteins and Antibodies
inferred← citeshttps://doi.org/10.1007/978-1-4939-2383-0_12openalex-snapshot
Spray-Drying of Biopharmaceuticals
inferred← citeshttps://doi.org/10.1007/978-3-030-35910-2_6openalex-snapshot
Respiratory Drug/Vaccine Delivery Using Nanoparticles
inferred← citeshttps://doi.org/10.1007/978-3-030-82918-6_13openalex-snapshot
Nanomedicine and Its Potential Therapeutic and Diagnostic Applications in Human Pathologies
inferred← citeshttps://doi.org/10.1007/978-3-031-59478-6_19openalex-snapshot
Peptides, Proteins and Antibodies
inferred← citeshttps://doi.org/10.1007/978-3-319-92067-2_32-1openalex-snapshot
Drug Delivery: Localized and Systemic Therapeutic Strategies with Polymer Systems
inferred← citeshttps://doi.org/10.1007/978-3-319-95987-0_32openalex-snapshot
Drug Delivery: Localized and Systemic Therapeutic Strategies with Polymer Systems
inferred← citeshttps://doi.org/10.1007/978-3-642-29265-1_1openalex-snapshot
Intellectual Property and Nanopharmaceuticals
inferred← citeshttps://doi.org/10.1007/978-981-16-4392-7_11openalex-snapshot
Recent Trends in Nanomedicine for Diagnosis and Treatment of Pulmonary Diseases
inferred← citeshttps://doi.org/10.1007/978-981-16-4392-7_8openalex-snapshot
Nanoparticles in Chronic Respiratory Diseases
inferred← citeshttps://doi.org/10.1007/978-981-19-7834-0_25openalex-snapshot
Routes of Nano-drug Administration and Nano-based Drug Delivery System and Toxicity
inferred← citeshttps://doi.org/10.1007/s00204-012-0876-5openalex-snapshot
Interactions of silica nanoparticles with lung epithelial cells and the association to flotillins
inferred← citeshttps://doi.org/10.1007/s00408-011-9360-xopenalex-snapshot
Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery
inferred← citeshttps://doi.org/10.1007/s00592-011-0356-zopenalex-snapshot
Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy
inferred← citeshttps://doi.org/10.1007/s10570-017-1498-0openalex-snapshot
Electrosprayed sperical ethylcellulose nanoparticles for an improved sustained-release profile of anticancer drug
inferred← citeshttps://doi.org/10.1007/s10853-020-05361-4openalex-snapshot
Polymeric micelles for pulmonary drug delivery: a comprehensive review
inferred← citeshttps://doi.org/10.1007/s11051-013-1560-2openalex-snapshot
Spherical agglomerates of pure drug nanoparticles for improved pulmonary delivery in dry powder inhalers
inferred← citeshttps://doi.org/10.1007/s11095-012-0891-5openalex-snapshot
Nanocarriers Targeting Dendritic Cells for Pulmonary Vaccine Delivery
inferred← citeshttps://doi.org/10.1007/s11095-014-1302-xopenalex-snapshot
Influence of Suspension Stabilisers on the Delivery of Protein-Loaded Porous Poly (DL-Lactide-co-Glycolide) (PLGA) Microparticles via Pressurised Metered Dose Inhaler (pMDI)
inferred← citeshttps://doi.org/10.1007/s11095-014-1538-5openalex-snapshot
Bovine Serum Albumin Adsorbed PGA-co-PDL Nanocarriers for Vaccine Delivery via Dry Powder Inhalation
inferred← citeshttps://doi.org/10.1007/s11095-026-04153-wopenalex-snapshot
Development of an In Vitro Permeation Test Framework For Naloxone Hydrochloride Intranasal Spray: Establishing IVIVR for Bioequivalence Assessment
inferred← citeshttps://doi.org/10.1007/s13346-012-0070-6openalex-snapshot
Advances in biomimetic regeneration of elastic matrix structures
inferred← citeshttps://doi.org/10.1007/s13346-017-0467-3openalex-snapshot
Challenge in particle delivery to cells in a microfluidic device
inferred← citeshttps://doi.org/10.1007/s40005-019-00443-1openalex-snapshot
Poly(lactic acid)/poly(lactic-co-glycolic acid) particulate carriers for pulmonary drug delivery
inferred← citeshttps://doi.org/10.1016/b978-0-08-088504-9.00338-xopenalex-snapshot
The Delivery of Drugs – Peptides and Proteins
inferred← citeshttps://doi.org/10.1016/b978-0-12-391860-4.00016-1openalex-snapshot
Peptide Nanomedicines for Treatment of Acute Lung Injury
inferred← citeshttps://doi.org/10.1016/b978-0-12-415759-0.00043-1openalex-snapshot
Nanoparticulates
inferred← citeshttps://doi.org/10.1016/b978-0-12-804543-5.00015-4openalex-snapshot
Nanotechnological applications for the control of pulmonary infections
inferred← citeshttps://doi.org/10.1016/b978-0-12-813689-8.00004-5openalex-snapshot
Target-specific delivery
inferred← citeshttps://doi.org/10.1016/b978-0-12-816662-8.00006-0openalex-snapshot
Routes of administration for nanocarriers
inferred← citeshttps://doi.org/10.1016/b978-0-12-818823-1.00005-3openalex-snapshot
Nanoparticle-Based Drug Delivery for Chronic Obstructive Pulmonary Disorder and Asthma
inferred← citeshttps://doi.org/10.1016/b978-0-12-820658-4.00012-1openalex-snapshot
Formulation and role of polymeric and inorganic nanoparticles in respiratory diseases
inferred← citeshttps://doi.org/10.1016/b978-0-12-820658-4.00021-2openalex-snapshot
Hydrogels for pulmonary drug delivery
inferred← citeshttps://doi.org/10.1016/b978-0-323-08593-9.00067-xopenalex-snapshot
Aerosols and Aerosol Drug Delivery Systems
inferred← citeshttps://doi.org/10.1016/b978-0-323-40016-9.00007-5openalex-snapshot
Nanopharmaceuticals
inferred← citeshttps://doi.org/10.1016/b978-0-323-42864-4.00003-8openalex-snapshot
Antimicrobial magnetosomes for topical antimicrobial therapy
inferred← citeshttps://doi.org/10.1016/b978-0-323-52725-5.00008-3openalex-snapshot
Nanoparticle System for Anticancer Drug Delivery: Targeting to Overcome Multidrug Resistance
inferred← citeshttps://doi.org/10.1016/b978-0-323-89839-3.00012-9openalex-snapshot
Nanoparticles for the targeted drug delivery in lung cancer
inferred← citeshttps://doi.org/10.1016/b978-0-323-91744-5.00015-1openalex-snapshot
Nanotechnology in biological science and engineering
inferred← citeshttps://doi.org/10.1016/b978-0-323-95325-2.00014-6openalex-snapshot
Utility of nanomedicine and nanocarriers for noninfectious disease treatment
inferred← citeshttps://doi.org/10.1016/b978-0-443-16153-7.00013-7openalex-snapshot
Nanoparticulates
inferred← citeshttps://doi.org/10.1016/b978-0-443-22374-7.00003-7openalex-snapshot
Effect of environment of the respiratory tract on nanomedicine drug delivery
inferred← citeshttps://doi.org/10.1016/b978-0-443-27345-2.00005-9openalex-snapshot
Enhanced drug delivery systems for the management of respiratory disorders
inferred← citeshttps://doi.org/10.1016/b978-0-443-33070-4.00006-xopenalex-snapshot
Nanobased strategies to combat bacterial pneumonia
inferred← citeshttps://doi.org/10.1016/b978-0-444-64046-8.00309-8openalex-snapshot
The Delivery of Drugs – Peptides and Proteins
inferred← citeshttps://doi.org/10.1016/j.addr.2010.11.002openalex-snapshot
Formation, characterization, and fate of inhaled drug nanoparticles
inferred← citeshttps://doi.org/10.1016/j.addr.2013.07.020openalex-snapshot
Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases
inferred← citeshttps://doi.org/10.1016/j.addr.2018.07.012openalex-snapshot
Electrohydrodynamic atomization and spray-drying for the production of pure drug nanocrystals and co-crystals
inferred← citeshttps://doi.org/10.1016/j.addr.2022.114173openalex-snapshot
Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?
inferred← citeshttps://doi.org/10.1016/j.addr.2023.114828openalex-snapshot
Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function
inferred← citeshttps://doi.org/10.1016/j.ajps.2019.02.001openalex-snapshot
Critical physicochemical attributes of chitosan nanoparticles admixed lactose-PEG 3000 microparticles in pulmonary inhalation
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2025.123420openalex-snapshot
Precision nanomedicine for pneumonocyte-targeting: Emerging strategies and clinical prospects in refractory pulmonary disease therapy
inferred← citeshttps://doi.org/10.1016/j.biopha.2019.108601openalex-snapshot
Recent advances in aerosolised drug delivery
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.112162openalex-snapshot
RETRACTED: Nanoparticles as an effective drug delivery system in COVID-19
inferred← citeshttps://doi.org/10.1016/j.carbpol.2011.03.022openalex-snapshot
Microspheres loaded with polysaccharide nanoparticles for pulmonary delivery: Preparation, structure and surface analysis
inferred← citeshttps://doi.org/10.1016/j.carbpol.2017.06.090openalex-snapshot
Microparticles prepared with 50–190 kDa chitosan as promising non-toxic carriers for pulmonary delivery of isoniazid
inferred← citeshttps://doi.org/10.1016/j.cbi.2021.109706openalex-snapshot
Protein and peptide delivery to lungs by using advanced targeted drug delivery
inferred← citeshttps://doi.org/10.1016/j.cej.2012.01.129openalex-snapshot
Lipids-based drug carrier systems by dense gas technology: A review
inferred← citeshttps://doi.org/10.1016/j.chemphyslip.2013.06.001openalex-snapshot
Liposome clusters with shear stress-induced membrane permeability
inferred← citeshttps://doi.org/10.1016/j.cis.2015.11.010openalex-snapshot
Recent advances in the engineering of nanosized active pharmaceutical ingredients: Promises and challenges
inferred← citeshttps://doi.org/10.1016/j.colsurfa.2016.11.006openalex-snapshot
Dynamic surface properties of mixed monolayers of polystyrene micro- and nanoparticles with DPPC
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2015.12.017openalex-snapshot
Disintegration of nano-embedded microparticles after deposition on mucus: A mechanistic study
inferred← citeshttps://doi.org/10.1016/j.ejpb.2010.02.014openalex-snapshot
A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung
inferred← citeshttps://doi.org/10.1016/j.ejpb.2011.04.017openalex-snapshot
Paclitaxel loaded PEG5000–DSPE micelles as pulmonary delivery platform: Formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation
inferred← citeshttps://doi.org/10.1016/j.ejpb.2011.12.014openalex-snapshot
Crosslinked chitosan nanoparticle formulations for delivery from pressurized metered dose inhalers
inferred← citeshttps://doi.org/10.1016/j.ejpb.2012.04.022openalex-snapshot
Pulmonary delivery and tissue distribution of aerosolized antisense 2′-O-Methyl RNA containing nanoplexes in the isolated perfused and ventilated rat lung
inferred← citeshttps://doi.org/10.1016/j.ejpb.2013.09.006openalex-snapshot
Real-time in vivo imaging of surface-modified liposomes to evaluate their behavior after pulmonary administration
inferred← citeshttps://doi.org/10.1016/j.ejpb.2024.114242openalex-snapshot
Tailoring lipid nanoparticles for T-cell targeting in allergic asthma: Insights into efficacy and specificity
inferred← citeshttps://doi.org/10.1016/j.ejps.2014.09.017openalex-snapshot
Redispersible liposomal-N-acetylcysteine powder for pulmonary administration: Development, in vitro characterization and antioxidant activity
inferred← citeshttps://doi.org/10.1016/j.ejps.2017.10.024openalex-snapshot
Nebulized coenzyme Q 10 nanosuspensions: A versatile approach for pulmonary antioxidant therapy
inferred← citeshttps://doi.org/10.1016/j.ejps.2021.106081openalex-snapshot
Design and evaluation of folate-modified liposomes for pulmonary administration in lung cancer therapy
inferred← citeshttps://doi.org/10.1016/j.ejps.2026.107495openalex-snapshot
Development and characterization of a carrier-free dry powder inhaler formulation of clarithromycin
inferred← citeshttps://doi.org/10.1016/j.heliyon.2020.e04864openalex-snapshot
Diclofenac-proline nano-co-crystal development, characterization, in vitro dissolution and diffusion study
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2020.09.163openalex-snapshot
Mannose-anchored N,N,N-trimethyl chitosan nanoparticles for pulmonary administration of etofylline
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2022.09.116openalex-snapshot
Pulmonary drug delivery applications of natural polysaccharide polymer derived nano/micro-carrier systems: A review
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2011.03.069openalex-snapshot
A novel bottom-up process to produce nanoparticles containing protein and peptide for suspension in hydrofluoroalkane propellants
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2011.10.051openalex-snapshot
Aerosolized semifluorinated alkanes as excipients are suitable for inhalative drug delivery—A pilot study
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2013.11.042openalex-snapshot
The impact of pulmonary diseases on the fate of inhaled medicines—A review
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2014.03.032openalex-snapshot
Formulation and evaluation of novel reverse microemulsions containing salmon calcitonin in hydrofluoroalkane propellants
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2014.05.062openalex-snapshot
Characterization of different vitamin E carriers intended for pulmonary drug delivery
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2015.07.008openalex-snapshot
Formulation and nebulization of fluticasone propionate-loaded lipid nanocarriers
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2016.04.038openalex-snapshot
Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2016.06.134openalex-snapshot
Fabrication of nanocomposite particles using a two-solution mixing-type spray nozzle for use in an inhaled curcumin formulation
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2018.02.008openalex-snapshot
Dry-powder formulations of non-covalent protein complexes with linear or miktoarm copolymers for pulmonary delivery
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2019.01.035openalex-snapshot
In vitro dissolution testing of respirable size anti-tubercular drug particles using a small volume dissolution apparatus
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2021.120805openalex-snapshot
Nanodelivery of a self-assembling prodrug with exceptionally high drug loading potentiates chemotherapy efficacy
inferred← citeshttps://doi.org/10.1016/j.jaerosci.2014.08.004openalex-snapshot
Generation, inhalation delivery and anti-hypertensive effect of nisoldipine nanoaerosol
inferred← citeshttps://doi.org/10.1016/j.jaerosci.2018.09.002openalex-snapshot
Multiphysics finite element modeling and validation of transient aerosol generation in an ultrasonic nebulizer drug delivery device
inferred← citeshttps://doi.org/10.1016/j.jcis.2010.12.032openalex-snapshot
Binding of chloroquine–conjugated gold nanoparticles with bovine serum albumin
inferred← citeshttps://doi.org/10.1016/j.jconrel.2011.04.019openalex-snapshot
A method for enhancing the ocular penetration of eye drops using nanoparticles of hydrolyzable dye
inferred← citeshttps://doi.org/10.1016/j.jconrel.2011.07.002openalex-snapshot
“Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era
inferred← citeshttps://doi.org/10.1016/j.jconrel.2013.01.011openalex-snapshot
Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension
inferred← citeshttps://doi.org/10.1016/j.jconrel.2014.03.022openalex-snapshot
Quantitative assessment of nanoparticle surface hydrophobicity and its influence on pulmonary biocompatibility
inferred← citeshttps://doi.org/10.1016/j.jconrel.2014.05.038openalex-snapshot
Respirable nanocarriers as a promising strategy for antitubercular drug delivery
inferred← citeshttps://doi.org/10.1016/j.jconrel.2015.05.269openalex-snapshot
In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery
inferred← citeshttps://doi.org/10.1016/j.jconrel.2020.07.002openalex-snapshot
Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases
inferred← citeshttps://doi.org/10.1016/j.jconrel.2020.07.011openalex-snapshot
Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery
inferred← citeshttps://doi.org/10.1016/j.jconrel.2024.07.034openalex-snapshot
Understanding the role of swirling flow in dry powder inhalers: Implications for design considerations and pulmonary delivery
inferred← citeshttps://doi.org/10.1016/j.jconrel.2025.01.017openalex-snapshot
The (re)emergence of aerosol delivery: Treatment of pulmonary diseases and its clinical challenges
inferred← citeshttps://doi.org/10.1016/j.jconrel.2026.115226openalex-snapshot
Fine-tuned machine learning models for the discovery of dye nanoparticles with enhanced lung delivery
inferred← citeshttps://doi.org/10.1016/j.jddst.2021.102664openalex-snapshot
Translation of pulmonary protein therapy from bench to bedside: Addressing the bioavailability challenges
inferred← citeshttps://doi.org/10.1016/j.jddst.2022.103186openalex-snapshot
Evaluation of various techniques for production of inhalable dry powders for pulmonary delivery of peptide and protein
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.105381openalex-snapshot
Nano-based carriers for pulmonary drug delivery: A review on the available drug delivery applications and toxicity issues
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.105648openalex-snapshot
“Nano-in-Micro” Structured Dry Powder Inhalers for pulmonary delivery: Advances and challenges
inferred← citeshttps://doi.org/10.1016/j.jphotobiol.2019.05.007openalex-snapshot
Synthesis and investigations of ciprofloxacin loaded engineered selenium lipid nanocarriers for effective drug delivery system for preventing lung infections of interstitial lung disease
inferred← citeshttps://doi.org/10.1016/j.matpr.2022.09.494openalex-snapshot
Nanostructure system: Liposome – A bioactive carrier in drug delivery systems
inferred← citeshttps://doi.org/10.1016/j.measurement.2021.109659openalex-snapshot
An integrated aerosol setup for therapeutics and toxicological testing: Generation techniques and measurement instrumentation
inferred← citeshttps://doi.org/10.1016/j.molliq.2023.123849openalex-snapshot
The role of the interface on surfactant transport to crude oil-water liquid-liquid interface
inferred← citeshttps://doi.org/10.1016/j.nano.2015.01.007openalex-snapshot
Inhalable nanoparticulate powders for respiratory delivery
inferred← citeshttps://doi.org/10.1016/j.nano.2016.03.002openalex-snapshot
Disposition and safety of inhaled biodegradable nanomedicines: Opportunities and challenges
inferred← citeshttps://doi.org/10.1016/j.nantod.2023.101998openalex-snapshot
Engineering of pulmonary surfactant corona on inhaled nanoparticles to operate in the lung system
inferred← citeshttps://doi.org/10.1016/j.powtec.2020.02.028openalex-snapshot
Carbohydrate-based Trojan microparticles as carriers for pulmonary delivery of lipid nanocapsules using dry powder inhalation
inferred← citeshttps://doi.org/10.1016/j.progpolymsci.2010.01.005openalex-snapshot
Non-viral polyplexes: Scaffold mediated delivery for gene therapy
inferred← citeshttps://doi.org/10.1016/j.rmed.2017.01.006openalex-snapshot
Optimizing drug delivery in COPD: The role of inhaler devices
inferred← citeshttps://doi.org/10.1016/j.rmr.2011.08.005openalex-snapshot
Prise en charge thérapeutique de l’atteinte des voies aériennes distales dans la BPCO
inferred← citeshttps://doi.org/10.1016/j.smaim.2024.04.001openalex-snapshot
Inhalable nanomedicine for lung cancer treatment
inferred← citeshttps://doi.org/10.1016/j.supflu.2018.07.027openalex-snapshot
Preparation of 5-fluorouracil microparticles and 5-fluorouracil/poly(l-lactide) composites by a supercritical CO2 antisolvent process
inferred← citeshttps://doi.org/10.1016/j.tiv.2015.09.030openalex-snapshot
Comparative safety evaluation of silica-based particles
inferred← citeshttps://doi.org/10.1016/j.xphs.2017.07.022openalex-snapshot
Optimization of Acetalated Dextran–Based Nanocomposite Microparticles for Deep Lung Delivery of Therapeutics via Spray-Drying
inferred← citeshttps://doi.org/10.1016/j.xphs.2020.11.016openalex-snapshot
Aerosol Inhalation Delivery of Triazavirin in Mice: Outlooks for Advanced Therapy Against Novel Viral Infections
inferred← citeshttps://doi.org/10.1016/s1773-2247(11)50052-8openalex-snapshot
In vivo safety and particokinetics of inhaled nanomedicines
inferred← citeshttps://doi.org/10.1016/s2213-2600(13)70072-9openalex-snapshot
Pulmonary drug delivery: from generating aerosols to overcoming biological barriers—therapeutic possibilities and technological challenges
inferred← citeshttps://doi.org/10.1021/acs.bioconjchem.4c00335openalex-snapshot
Poly(malic acid) Nanoconjugates of Pyrazinoic Acid for Lung Delivery in the Treatment of Tuberculosis
inferred← citeshttps://doi.org/10.1021/acs.chemrestox.6b00377openalex-snapshot
Pitfalls and Challenges in Nanotoxicology: A Case of Cobalt Ferrite (CoFe2O4) Nanocomposites
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.6b00069openalex-snapshot
Hyaluronic Acid Molecular Weight Determines Lung Clearance and Biodistribution after Instillation
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.8b01288openalex-snapshot
Minocycline and Silver Dual-Loaded Polyphosphoester-Based Nanoparticles for Treatment of Resistant Pseudomonas aeruginosa
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.9b01166openalex-snapshot
Using Polar Ion-Pairs to Control Drug Delivery to the Airways of the Lungs
inferred← citeshttps://doi.org/10.1021/acsami.2c20479openalex-snapshot
Pulmonary Delivery of Recombinant Human Bleomycin Hydrolase Using Mannose-Modified Hierarchically Porous UiO-66 for Preventing Bleomycin-Induced Pulmonary Fibrosis
inferred← citeshttps://doi.org/10.1021/acsinfecdis.5c01153openalex-snapshot
Nitric Oxide-Releasing Therapeutics for Treating Bacterial Infections: Anatomical Targeting and Therapeutic Design
inferred← citeshttps://doi.org/10.1021/acsomega.2c06384openalex-snapshot
Scalable Inhibitors of the Nsp3–Nsp4 Coupling in SARS-CoV-2
inferred← citeshttps://doi.org/10.1021/cr300047qopenalex-snapshot
Can Controversial Nanotechnology Promise Drug Delivery?
inferred← citeshttps://doi.org/10.1021/mp400091nopenalex-snapshot
Pulmonary Administration of PEGylated Polylysine Dendrimers: Absorption from the Lung versus Retention within the Lung Is Highly Size-Dependent
inferred← citeshttps://doi.org/10.1021/nn4054683openalex-snapshot
Physicochemical Properties of Nanoparticles Regulate Translocation across Pulmonary Surfactant Monolayer and Formation of Lipoprotein Corona
inferred← citeshttps://doi.org/10.1038/aps.2009.15openalex-snapshot
Composite glycidyl methacrylated dextran (Dex-GMA)/gelatin nanoparticles for localized protein delivery
inferred← citeshttps://doi.org/10.1038/s41392-019-0068-3openalex-snapshot
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
inferred← citeshttps://doi.org/10.1038/srep22731openalex-snapshot
Inter-molecular β-sheet structure facilitates lung-targeting siRNA delivery
inferred← citeshttps://doi.org/10.1039/9781837676439-00005openalex-snapshot
Nanomaterials Used in Inhaled Pulmonary Delivery Systems
inferred← citeshttps://doi.org/10.1039/9781837676439-00250openalex-snapshot
Harnessing Inhaled Nanoparticles for Enhanced Pharmacokinetics and Pharmacodynamics of Drugs
inferred← citeshttps://doi.org/10.1039/9781849735292-00239openalex-snapshot
Nanostructures for Overcoming the Pulmonary Barriers: Physiological Considerations and Mechanistic Issues
inferred← citeshttps://doi.org/10.1039/9781849735292-00273openalex-snapshot
Nanostructures for Overcoming the Pulmonary Barrier: Drug Delivery Strategies
inferred← citeshttps://doi.org/10.1039/c3nr01525dopenalex-snapshot
Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation
inferred← citeshttps://doi.org/10.1039/c5cs00541hopenalex-snapshot
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles
inferred← citeshttps://doi.org/10.1039/c6ra19789bopenalex-snapshot
Taste masking of a drug by pH-responsive coordination polymer-coated mesoporous silica nanoparticles
inferred← citeshttps://doi.org/10.1039/c9ra04978aopenalex-snapshot
Hydrothermal synthesis, characterization and enhanced photocatalytic activity and toxicity studies of a rhombohedral Fe 2 O 3 nanomaterial
inferred← citeshttps://doi.org/10.1039/d1na00205hopenalex-snapshot
Inhaled antibiotic-loaded polymeric nanoparticles for the management of lower respiratory tract infections
inferred← citeshttps://doi.org/10.1039/d2ra02859jopenalex-snapshot
Biophysical analysis of gelatin and PLGA nanoparticle interactions with complex biomimetic lung surfactant models
inferred← citeshttps://doi.org/10.1063/5.0162912openalex-snapshot
A review on herbal nano drug delivery systems: A new skyline
inferred← citeshttps://doi.org/10.1073/pnas.1502281112openalex-snapshot
Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy
inferred← citeshttps://doi.org/10.1080/00914037.2016.1236339openalex-snapshot
N-acetylcysteine-loaded PLGA nanoparticles outperform conventionalN-acetylcysteine in acute lung injuriesin vivo
inferred← citeshttps://doi.org/10.1080/02786826.2010.498797openalex-snapshot
Size Distribution and Morphology of Liposome Aerosols Generated By Two Methodologies
inferred← citeshttps://doi.org/10.1080/08927022.2017.1342118openalex-snapshot
Effect of the surface charge density of nanoparticles on their translocation across pulmonary surfactant monolayer: a molecular dynamics simulation
inferred← citeshttps://doi.org/10.1080/08958370903005769openalex-snapshot
Low cytotoxicity of solid lipid nanoparticles inin vitroandex vivolung models
inferred← citeshttps://doi.org/10.1080/1061186x.2025.2554761openalex-snapshot
Mannosylated chitosan-decorated PLGA nanoparticles for targeted pulmonary delivery of isoniazid: a promising approach in the treatment of tuberculosis
inferred← citeshttps://doi.org/10.1080/10717544.2016.1269850openalex-snapshot
Anhydrous reverse micelle nanoparticles: new strategy to overcome sedimentation instability of peptide-containing pressurized metered-dose inhalers
inferred← citeshttps://doi.org/10.1080/10837450.2023.2251148openalex-snapshot
Inhalable spray-dried polycaprolactone-based microparticles of Sorafenib Tosylate with promising efficacy on A549 cells
inferred← citeshttps://doi.org/10.1080/17458080.2015.1025303openalex-snapshot
Formulation and characterisation of nanosuspension of herbal extracts for enhanced antiradical potential
inferred← citeshttps://doi.org/10.1080/17476348.2026.2644609openalex-snapshot
Advances in biologic therapies for COPD: precision medicine approaches and implications for small-airway disease
inferred← citeshttps://doi.org/10.1088/0957-4484/22/6/065604openalex-snapshot
PEG based hyperbranched polymeric hollow nanospheres
inferred← citeshttps://doi.org/10.1088/0957-4484/27/39/395601openalex-snapshot
The generation of myricetin–nicotinamide nanococrystals by top down and bottom up technologies
inferred← citeshttps://doi.org/10.1088/1757-899x/547/1/012028openalex-snapshot
The Influence of Chitosan Concentration on Polyelectrolytes Complexes (PECs) of Chitosan – Poly-2-Acrylamido-2-Methylprophane Sulfonic Acid (PAMPS) as Potential Drug Carrier in Pulmonary Delivery Application
inferred← citeshttps://doi.org/10.1089/jamp.2010.0838openalex-snapshot
Pulmonary Formulations: What Remains to be Done?
inferred← citeshttps://doi.org/10.1089/jamp.2010.0853openalex-snapshot
Inhaler Devices: What Remains to be Done?
inferred← citeshttps://doi.org/10.1089/jamp.2013.1117openalex-snapshot
Physicochemical Characterization of Nebulized Superparamagnetic Iron Oxide Nanoparticles (SPIONs)
inferred← citeshttps://doi.org/10.1089/jamp.2024.29117.mkopenalex-snapshot
Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery
inferred← citeshttps://doi.org/10.1109/access.2019.2961513openalex-snapshot
Environmental and Societal Impact of Nanotechnology
inferred← citeshttps://doi.org/10.1111/bph.12604openalex-snapshot
Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling
inferred← citeshttps://doi.org/10.1128/aac.00517-20openalex-snapshot
Therapeutic Efficacy of Novel Antimicrobial Peptide AA139-Nanomedicines in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats
inferred← citeshttps://doi.org/10.1128/aac.01634-12openalex-snapshot
Efficacy of Liposomal Bismuth-Ethanedithiol-Loaded Tobramycin after Intratracheal Administration in Rats with Pulmonary Pseudomonas aeruginosa Infection
inferred← citeshttps://doi.org/10.1155/2011/163791openalex-snapshot
Evaluating the Controlled Release Properties of Inhaled Nanoparticles Using Isolated, Perfused, and Ventilated Lung Models
inferred← citeshttps://doi.org/10.1155/2011/507508openalex-snapshot
A Novel Aerosol Method for the Production of Hydrogel Particles
inferred← citeshttps://doi.org/10.1155/2011/808967openalex-snapshot
Protective Effects of Liposomal N-Acetylcysteine against Paraquat-Induced Cytotoxicity and Gene Expression
inferred← citeshttps://doi.org/10.1155/2013/848275openalex-snapshot
Quantum Dot-Loaded Liposomes to Evaluate the Behavior of Drug Carriers after Oral Administration
inferred← citeshttps://doi.org/10.1155/2015/216375openalex-snapshot
Nanosuspension Technologies for Delivery of Poorly Soluble Drugs
inferred← citeshttps://doi.org/10.1155/2015/394507openalex-snapshot
The Transport and Deposition of Nanoparticles in Respiratory System by Inhalation
inferred← citeshttps://doi.org/10.1159/000477086openalex-snapshot
Nanomedicine for Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
inferred← citeshttps://doi.org/10.11606/t.9.2023.tde-08032024-143847openalex-snapshot
Development and evaluation of flubendazole inhalable nanoparticles for lung cancer treatmen
inferred← citeshttps://doi.org/10.1177/1934578x1300800129openalex-snapshot
Challenges of Curcumin Bioavailability: Novel Aerosol Remedies
showing the first 200 of 294 · page through all 294
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.